PARTI Overview We are engaged in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal ( GI ) diseases. Non-systemic therapies are non-absorbable drugs that act locally, i.e., in the intestinal lumen, skin or mucosa, without reaching an individuals systemic circulation. In May 2024, we changed our name from First Wave Biopharma, Inc. to Entero Therapeutics, Inc. We are currently focused on developing the biologic Adrulipase, a recomb...
Q2 FY2026 — expected 2026-09-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-04-01 | 2024-12-31 | 0001410578-25-000618 | EDGAR | 84K words |
| 2024-03-29 | 2023-12-31 | 0001410578-24-000364 | EDGAR | — |
| 2023-03-20 | 2022-12-31 | 0001410578-23-000299 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001140361-22-012347 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001654954-21-003659 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001654954-20-003530 | EDGAR | — |
| 2019-04-01 | 2018-12-31 | 0001654954-19-003863 | EDGAR | — |
| 2018-03-16 | 2017-12-31 | 0001654954-18-002715 | EDGAR | — |
| 2017-03-31 | 2016-12-31 | 0001654954-17-002925 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-19 | 2025-09-30 | 0001104659-25-114181 | EDGAR | 34K words |
| 2025-08-14 | 2025-06-30 | 0001410578-25-001790 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001410578-25-001311 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001410578-24-001914 | EDGAR | — |
| 2024-10-21 | 2024-06-30 | 0001410578-24-001685 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001410578-24-000826 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001410578-23-002410 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001410578-23-001882 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001410578-23-001056 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001410578-22-003295 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001410578-22-002519 | EDGAR | — |
| 2022-05-23 | 2022-03-31 | 0001410578-22-001818 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-23 | 0001104659-26-086250 | EDGAR | — |
| 2026-01-07 | 0001104659-26-001755 | EDGAR | 3K words |
| 2025-12-23 | 0001104659-25-124213 | EDGAR | — |
| 2025-12-04 | 0001104659-25-118524 | EDGAR | — |
| 2025-11-06 | 0001104659-25-107715 | EDGAR | — |
| 2025-10-31 | 0001104659-25-104917 | EDGAR | — |
| 2025-10-22 | 0001104659-25-101519 | EDGAR | — |
| 2025-10-06 | 0001104659-25-097138 | EDGAR | — |
| 2025-09-12 | 0001104659-25-089562 | EDGAR | — |
| 2025-09-09 | 0001104659-25-088663 | EDGAR | — |
320 total filings indexed. 289 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001604191 |
| Ticker | GRDX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.enterothera.com |
| Listed | 2016-10-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/GRDX (~200 tokens, structured JSON with cryptographic provenance)